Pascal touchon
WebPASCAL TOUCHON This Executive Employment Agreement (this “ Agreement ”), is made and entered into as of May 23, 2024 (the “ Effective Date ”), by and between Pascal Touchon (“ Employee ”) and Atara Biotherapeutics, Inc. (the “ Company ”). 1. Employment by the Company. 1.1 Position. WebPascal Touchon President & CEO Atara Biotherapeutics. With more than 30 years of global biopharmaceutical leadership experience, Pascal Touchon joined Atara Biotherapeutics as President, Chief Executive Officer and member of the Board of Directors in June 2024. Dr Touchon has committed his career to transforming the lives of patients with ...
Pascal touchon
Did you know?
Web1 Mar 2024 · Pascal Touchon. And related to the 1XX domain, that’s something, as you know, that we’ve been using in this stage in different contracts for allogeneic CAR T program as well as in the case of ... WebPresently, Pascal Touchon is President, Chief Executive Officer & Director at Atara Biotherapeutics, Inc. Dr. Touchon is also on the board of Cogen Immune Medicine, Inc. …
Web2 Dec 2024 · With more than 30 years of global biopharmaceutical leadership experience, Pascal Touchon has committed his career to transform the lives of patients with serious medical conditions. Before joining Atara Biotherapeutics Dr. Touchon was Global Head, Cell & Gene and member of the Oncology Executive Committee at Novartis Oncology, where … Web30 Mar 2024 · In December 2024, Atara Biotherapeutics’ Ebvallo received European Commission approval as the first-ever therapy for adults and children with EBV+ PTLD. The ...
WebPascal Touchon - President and CEO/ Member of the Board of Directors - Atara Biotherapeutics LinkedIn. Experienced strategic and operational biopharmaceutical … WebPascal Touchon President & CEO Atara Biotherapeutics With more than 30 years of global biopharmaceutical leadership experience, Pascal Touchon joined Atara Biotherapeutics …
Web30 Mar 2024 · Atara Bio's CEO, Pascal Touchon, talks to Cell & Gene: The Podcast's Erin Harris about the biopharma's path to regulatory approval, commercialization plans for Ebvallo, an in-depth look at EBV+ PTLD, the connection between EBV and serious diseases like multiple sclerosis (MS), and much more. 40 min 16 MAR 2024
Web28 May 2024 · Previously at Novartis, Pascal Touchon served as Global Head, Strategy, Business Development, Oncology where he was responsible for various activities … cursed places in the worldchart targetWebPascal Touchon. CEO at Atara Biotherapeutics. Agenda Sessions. Cell Therapy Milestones in 2024. Jan 09, 09:05. View Session. Speakers at this event. Prev. Next. Alice Valder Curran. … charttechnik trompeteWeb2 Mar 2024 · What is Pascal Touchon's net worth? The estimated net worth of Pascal Touchon is at least $2.14 million as of March 2nd, 2024. Dr. Touchon owns 750,728 shares of Atara Biotherapeutics stock worth more than $2,139,575 as of March 20th. This net worth evaluation does not reflect any other investments that Dr. Touchon may own. chart tattoo painWeb4 Nov 2024 · Pascal Touchon Yes. And again, Jon, I think, as we say, the specifics of what we can say are going to be clarified at the time of the IA, because that depends very much from the data. chart table differenceWeb1 Mar 2024 · Atara Biotherapeutics, Inc. (ATRA) CEO Pascal Touchon on Q4 2024 Results - Earnings Call Transcript. Feb. 28, 2024 10:49 PM ET Atara Biotherapeutics, Inc. (ATRA) SA … charttechnik death crossWebPascal Touchon President and Chief Executive Officer With more than 30 years of global biopharmaceutical leadership experience, Pascal Touchon joined Atara Biotherapeutics … chart tank cryogenic